Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographis paniculata extract for asymptomatic or mild COVID-19
TCTR20211224002Phase 3Recruiting
- Sponsor
- Health Systems Research Institute
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of andrographis paniculata extract in coronavirus disease 2019 (COVID-19), sponsored by Health Systems Research Institute. Started Dec 2021; status: recruiting.
02
Drugs
andrographis paniculata extract
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211224002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211224002.